ChromaDex announced its inclusion in the Russell 2000 Index as part of the annual reconstitution of the Russell stock indexes. This inclusion will be effective at the opening of U.S. equity markets on Monday, July 1, based on the preliminary list of additions posted on Friday, May 24.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXC:
- ChromaDex CFO Brianna Gerber Announces Resignation
- ChromaDex announces results from phase II study of NR supplementation
- ChromaDex receives orphan drug designation for Ataxia Telangiectasia cadidate
- ChromaDex price target raised to $6.70 from $6.40 at Ladenburg
- ChromaDex sees FY24 revenue growth higher than FY23